Clinical Trials
248 trialsA Phase II Study of Aumolertinib Combined With Phased Chemotherapy for EGFR L858R Lung Adenocarcinoma
Taipei Medical University Hospital
A Study of Tumor-Treating Fields (TTFields) in People With Lung Adenocarcinoma
Memorial Sloan Kettering Cancer Center
Clinical Application of PET Imaging Targeting MSLN in Malignant Tumors
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer
NRG Oncology
Shared Decision Making in Patients With Lung Cancer
Sichuan Cancer Hospital and Research Institute
Osimertinib to Suppress the Progression of Remaining GGN for EGFR Mutation-positive Stage IB-IIIA Lung Adenocarcinoma
Samsung Medical Center
Stereotactic Body Radiation Therapy With or Without Nivolumab in Treating Patients With Stage I-IIA or Recurrent Non-small Cell Lung Cancer
M.D. Anderson Cancer Center
Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm
Shanghai Pulmonary Hospital, Shanghai, China
Pathogenic Variants in Genes Associated With Lung Adenocarcinoma
Instituto Nacional de Cancerologia de Mexico
Defactinib, Avutometinib and Nivolumab for the Treatment of Anti-PD1 Refractory LKB1-Mutant Advanced Non-Small Cell Lung Cancer
Emory University
Bevacizumab Plus FSRT Versus Hippocampus-Avoidant WBRT in Lung Adenocarcinoma With Extensive Brain Metastases
Sun Yat-sen University
Using Biomarkers for Diagnosis, Risk Stratification of Post -Treatment Recurrence and Long-Term Surveillance of Lung Cancer
H. Lee Moffitt Cancer Center and Research Institute
Nivolumab and Ipilimumab With or Without Local Consolidation Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer
M.D. Anderson Cancer Center
KETO-FDG Lung
Fondazione del Piemonte per l'Oncologia
Furmonertinib Plus Radiotherapy for EGFR+ NSCLC With Pleural Effusion
Jiangmen Central Hospital
Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Pleural Effusion Biomarkers in Lung Adenocarcinoma Patients
Fu Jen Catholic University
EVLC
Palo Alto Veterans Institute for Research
Image-Guided Hypofractionated Radiation Therapy With Stereotactic Body Radiation Therapy Boost and Combination Chemotherapy in Treating Patients With Stage II-III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery
Jonsson Comprehensive Cancer Center
Partial Tumor Irradiation and Immunotherapy for Unresectable Lung Cancer
Karl Landsteiner University of Health Sciences
BLCIO
Ohio State University Comprehensive Cancer Center
Testing the Safety of Dapagliflozin Prior to Surgery for the Treatment of Patients With Stage IA Lung Adenocarcinoma
Jonsson Comprehensive Cancer Center
PHOENIX
Guangdong Association of Clinical Trials
Peripheral Blood ETASTs for Predicting Efficacy of Chemoimmunotherapy in NSCLC
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
CRYOMUNE
Institut Bergonié
Evaluation of Different Sizes of Left-Sided Double-Lumen Tubes for Thoracic Surgery in a Tertiary Level Teaching Hospital
Tribhuvan University, Nepal
Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer
Alliance for Clinical Trials in Oncology
Prediction of Targeted Therapy Efficacy in EGFR-mutant Lung Cancer Patients Using AI-based Multimodal Data
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
ALDH
Kaohsiung Medical University
An Investigational Scan (Me-4FDG PET/CT) for the Detection of Sodium-Glucose Transport for Early Diagnosis of Lung Cancer
Jonsson Comprehensive Cancer Center
MOv19-BBz CAR T Cells in FRa+ Cancers
University of Pennsylvania
RESET
Stony Brook University
STAR012
Shanghai Pulmonary Hospital, Shanghai, China
RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial
Masonic Cancer Center, University of Minnesota
Sirolimus and Auranofin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer or Small Cell Lung Cancer
Mayo Clinic
Testing the Effects of MK-3475 (Pembrolizumab) With or Without the Usual Chemotherapy Treatment for Patients 70 Years of Age and Older With Advanced Non-small Cell Lung Cancer
Alliance for Clinical Trials in Oncology
DNA Methylation Biomarkers to Predict Survival After Surgery for Lung Adenocarcinoma
Nanjing University
Comparison Paravertebral and Serratus Anterior Plane Block in Video-assisted Thoracoscopic Surgery.
Hacettepe University
Sleep State in Lung Cancer: A Retrospective Analysis
Shanghai Zhongshan Hospital
CAR T Cells in Mesothelin Expressing Cancers
University of Pennsylvania
ACROPOLI
SOLTI Breast Cancer Research Group
Lorlatinib Compared with Concurrent/ Sequential Chemoradiotherapy in Stage III ALK Positive Lung Adenocarcinoma
Guangdong Association of Clinical Trials
Primary Tumor Resection With EGFR TKI for Stage IV NSCLC
National Taiwan University Hospital
OOTER
Tongji Hospital
18F-FDG and 68Ga-FAPI PET/CT in Lung Adenocarcinoma
The First Affiliated Hospital of Xiamen University
TEG
University of Colorado, Denver
Lung Cancer Mutation Consortium Protocol
University of Colorado, Denver
Lymph Node Pathologic Grading Strategy
Fudan University
Plasma Exosomes Reveal the Efficacy of Targeted Therapy in Patients With EGFR Mutation in Lung Adenocarcinoma
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Vinorelbine and Bevacizumab in Treating Older Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
University of Rochester